Health Condition 1: K053- Chronic periodontitis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Individuals aged 30 to 65 years. Patients clinically diagnosed with periodontitis. Patients should be diagnosed with type II Diabetes mellitus Individuals willing to receive periodontal treatment and adhere to scheduled recall visits. Participants who provide voluntary written informed consent. Patients diagnosed with Stage III Grade B periodontitis.
Exclusion criteria
Exclusion criteria: Patients who have undergone periodontal treatment in the last six months. Subjects on antibiotics anti-inflammatory medications or immunosuppressive drugs within the last three months. Smokers alcoholics and tobacco users Pregnant or lactating mother. Individuals with ongoing infections or blood disorders that may influence leukocyte parameters. Patients with systemic conditions other than diabetes mellitus that may affect periodontal health . Patients with Stage I and II Periodontitis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To examine the relationship between post treatment variations in clinical periodontal parameters and the Aggregate Index Of Systemic Inflammation(AISI)Timepoint: at baseline and after 6 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| To record the baseline clinical periodontal findings and glycemic parameters in individual with type II diabetes mellitus presenting with periodontitis. to assess baseline hematological values required for calculating the aggregate index of systemic inflammation(AISI). to carry out non-surgical periodontal treatment in type II diabetic patients diagnosed with periodontitis. to reassess periodontal clinical findings and to corelate with the aggregate index of systemic inflammation(AISI) after 6 to 8 weeks after non surgical periodontal therapy before flap surgery as a routine blood investigation. Timepoint: at baseline and after 6 weeks | — |
Countries
India
Contacts
KVG Dental college and hospital sullia